Advanced Light Therapy Begins at PAU Hospitals
The Department of Dermatology and Venereology at Pamukkale University (PAU) Hospitals is providing targeted and effective treatments for challenging skin diseases with the state-of-the-art “Excimer Light” device, acquired with the support of Dr. Halis Ödel.
Prof. Dr. Ahmet Metin, Head of the Department of Dermatology and Venereology at PAU Hospitals, made the following statements about the device: “As Pamukkale University, we continue to improve our clinical facilities in line with our mission of delivering qualified healthcare services to all segments of society and guiding medicine through scientific research. In this context, the Kernel 5000 D brand Excimer Light device, donated by businessman Dr. Halis Ödel on behalf of Denizlipek Textile Production and Foreign Trade Ltd. Co. for use in our dermatology clinic, has met an important need. The number of patients requiring phototherapy in our clinic is increasing day by day. Thanks to this new generation device, we are able to offer more comfortable, faster, and more effective solutions to our patients, especially in skin diseases with long and difficult treatment processes. This technology, which provides targeted treatment opportunities in resistant skin diseases such as vitiligo, psoriasis, eczema, alopecia areata, and rosacea, applies 308 nm ultraviolet light only to the affected area, protecting healthy tissue and minimizing the risk of side effects. This significantly contributes to shortening treatment times and improving the quality of life of our patients. At the same time, this device will play an important role not only in patient treatment but also in our academic studies. Our assistant physicians receiving specialization training in dermatology will have the opportunity to work with up-to-date technologies, our scientific research infrastructure will be strengthened, and studies contributing to international literature will be made possible. This advanced technology device donated by Dr. Halis Ödel will particularly provide targeted treatment opportunities for our patients with localized vitiligo and psoriasis, accelerating their healing processes. We believe that this device, one of the most up-to-date tools of evidence-based medicine, will both improve our patient care quality and contribute to our academic productivity. We would like to express our gratitude to him on behalf of our clinic and our patients.”